SCHEMBL2299338

SCHEMBL2299338

O=C1NCCN1c1ccc(S(=O)(=O)O)c(-c2cccc(F)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.39
PTGS2 P35354 2/20 0.38
PARP10 Q53GL7 1/20 0.38
PARP11 Q9NR21 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
EIF2AK2 P19525 1/20 0.36
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
TDO2 P48775 1/20 0.36
HTR6 P50406 2/20 0.35
HTR1A P08908 1/20 0.35
DRD2 P14416 1/20 0.35
HTR2A P28223 1/20 0.35
HTR7 P34969 1/20 0.35
PTPN1 P18031 1/20 0.34
P2RY4 P51582 1/20 0.34
MCHR1 Q99705 1/20 0.34
NISCH Q9Y2I1 1/20 0.34
ALOX5 P09917 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14119542 0.94 HTR6 (0.40) HCRTR1PTGS2PARP10PARP11NPC1
SCHEMBL2299608 0.89 ALOX5 (0.39) HCRTR1NPC1RAB9AEIF2AK2ALOX5AP
SCHEMBL2302675 0.88 ALOX5 (0.42) PTGS2PARP10PARP11RAB9AEIF2AK2
SCHEMBL2301978 0.88 ALDH1A1 (0.38) EIF2AK2ALOX5APFEN1HTR6ALOX5
SCHEMBL2303927 0.88 EIF2AK2 (0.43) EIF2AK2ALOX5APFEN1HTR6ALOX5
SCHEMBL2304873 0.87 EIF2AK2 (0.36) EIF2AK2TDO2ALOX5
SCHEMBL14119429 0.87 POLB (0.41) PTGS2PARP10PARP11EIF2AK2NISCH
SCHEMBL2307068 0.87 TDO2 (0.40) EIF2AK2ALOX5APFEN1TDO2HTR6
SCHEMBL2299702 0.86 ALOX5AP (0.38) HCRTR1PTGS2ALOX5APFEN1TDO2
SCHEMBL2306298 0.85 TDO2 (0.39) HCRTR1EIF2AK2ALOX5APFEN1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034888-B2 Substituted 2-imidazolidones and analogs UNIVERSITE LAVAL (CA) 2015-05-19 US disclosed
EP-2536693-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS Université Laval (CA) 2012-12-26 EP disclosed
US-20120309777-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS UNIVERSITE LAVAL (CA) 2012-12-06 US disclosed
WO-2011100840-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS UNIVERSITé LAVAL (CA) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309777-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS CCNY, RPS4Y1, TPX2 HCRTR1 2662/4885PTGS2 4019/4885PARP10 950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.